Is ceftriaxone (a broad-spectrum cephalosporin antibiotic) 2g intravenous (IV) twice daily (bid) an appropriate treatment for a brain infection caused by Cutibacterium acnes that is sensitive to penicillin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone 2g IV BID is NOT the Optimal Treatment for Penicillin-Sensitive Cutibacterium acnes Brain Infection

For penicillin-sensitive Cutibacterium acnes brain infections, high-dose intravenous penicillin G (20-24 million units daily in divided doses) is the preferred first-line treatment, not ceftriaxone. 1, 2, 3

Guideline-Based Treatment Recommendations

First-Line Therapy

  • Penicillin G 20 million units IV every 24 hours (continuous infusion or divided into 6 doses) is the preferred treatment for Cutibacterium acnes CNS infections 1
  • Alternative regimen: Ceftriaxone 2g IV every 24 hours (once daily, not twice daily) is listed as an acceptable alternative, but NOT as first-line therapy 1
  • Treatment duration: 4-6 weeks of intravenous therapy 1

Alternative Agents (If Penicillin Cannot Be Used)

  • Clindamycin 600-900 mg IV every 8 hours or 300-450 mg PO four times daily 1
  • Vancomycin 15 mg/kg IV every 12 hours 1

Why Ceftriaxone 2g BID is Inappropriate

Dosing Frequency Error

  • Ceftriaxone for C. acnes is dosed once daily (2g every 24 hours), not twice daily 1
  • The twice-daily dosing (2g every 12 hours) is reserved for bacterial meningitis caused by organisms like Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae 1, 4, 5, 6
  • C. acnes does not require the aggressive twice-daily dosing needed for rapidly dividing pyogenic bacteria 1

Suboptimal Antimicrobial Choice

  • Penicillin G demonstrates superior clinical outcomes for C. acnes CNS infections with minimal inhibitory concentrations (MICs) ranging from 0.03-0.12 mg/L 2
  • Historical case series show excellent cure rates with high-dose penicillin (3-4 million units IV every 4 hours) combined with surgical drainage 2, 3
  • C. acnes is an indolent, slow-growing anaerobe that responds best to beta-lactams with narrow spectrum activity 2, 3, 7

Clinical Algorithm for C. acnes Brain Infection

Step 1: Confirm Diagnosis

  • Obtain anaerobic cultures from surgical specimens (C. acnes is frequently missed on routine aerobic cultures) 8, 7
  • Look for Gram-positive bacilli on Gram stain—this should NOT be dismissed as contamination in neurosurgical specimens 7
  • Expect indolent presentation with delayed onset (median 54 days post-surgery, range 12-1,578 days) 7

Step 2: Surgical Management

  • Remove all foreign bodies (shunts, bone flaps, prosthetic devices) 2, 3, 7
  • Perform surgical drainage of purulent collections (abscesses, subdural empyemas) 2, 3
  • C. acnes produces biofilm on prosthetic devices, making medical therapy alone insufficient 8

Step 3: Antimicrobial Therapy

  • If penicillin-sensitive: Penicillin G 20-24 million units IV daily (divided every 4 hours or continuous infusion) 1, 2, 3
  • If penicillin allergy or intolerance: Ceftriaxone 2g IV once daily (every 24 hours) 1
  • Duration: 4-6 weeks of intravenous therapy 1, 3
  • For extracranial bone-flap infections: Consider shorter courses (≤7 days IV) after hardware removal 7

Step 4: Monitoring

  • Serial imaging to confirm resolution of infectious collections 3
  • Monitor for relapse or reinfection (occurs in approximately 7% of cases) 7
  • No adverse reactions to high-dose penicillin were reported in published case series 2

Common Pitfalls to Avoid

  • Do not dismiss Gram-positive bacilli on Gram stain as contaminants—this is often C. acnes in neurosurgical specimens 7
  • Do not rely solely on routine aerobic cultures—obtain anaerobic cultures for all CNS infections with foreign bodies 8, 7
  • Do not use ceftriaxone twice daily dosing—this wastes resources and provides no additional benefit for C. acnes 1
  • Do not attempt medical therapy alone without removing infected hardware—biofilm production makes this approach futile 8
  • Do not use short treatment courses—intracranial C. acnes infections require 4-6 weeks of IV therapy 1, 3

Special Populations

Immunosuppressed Patients

  • Higher susceptibility to C. acnes CNS infections despite the organism's typically benign nature 3
  • Maintain same treatment principles: surgical drainage + prolonged IV penicillin 3

Prosthetic Joint Infection Guidelines (Extrapolated)

  • The IDSA prosthetic joint infection guidelines also recommend penicillin G as first-line for C. acnes, with ceftriaxone 2g once daily as an alternative 1
  • This reinforces the principle that penicillin remains superior for penicillin-sensitive C. acnes regardless of infection site 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ceftriaxone Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Meningitic Dosing of Ceftriaxone-Sulbactam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ceftriaxone Dosing for CNS Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A Case of Coccidioidal Meningitis With Biofilm Obstructing VP Shunt Due to Cutibacterium acnes.

Journal of investigative medicine high impact case reports, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.